TJPC(SH:600488) 智通财经网·2025-11-04 07:41Core Viewpoint - Tianjin Pharmaceutical Industry Co., Ltd. (stock code: 600488.SH) announced that its subsidiary, Tianjin Pharmaceutical Peace Co., Ltd., received approval from the National Medical Products Administration for the potassium hydrogen phosphate injection, which has passed the consistency evaluation of generic drug quality and efficacy [1] Group 1 - The potassium hydrogen phosphate injection is primarily used as a phosphorus supplement for correcting hypophosphatemia in adult and pediatric patients when oral or enteral nutrition is not feasible, insufficient, or contraindicated [1] - The injection is also indicated for parenteral nutrition in adult and pediatric patients under similar conditions [1] - Tianjin Pharmaceutical Peace submitted a supplementary application for the consistency evaluation of the potassium hydrogen phosphate injection to the National Medical Products Administration in July 2024, which has been accepted [1] Group 2 - The total research and development investment in the potassium hydrogen phosphate injection project by Tianjin Pharmaceutical Peace has reached approximately 9.21 million yuan [1]